Holen Sie sich die Stockscreener-App
21.90
4.62%
-1.06
Handel nachbörslich:
22.32
0.42
+1.92%
Schlusskurs vom Vortag:
$22.96
Offen:
$22.9
24-Stunden-Volumen:
1.20M
Relative Volume:
0.64
Marktkapitalisierung:
$1.40B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-107.85M
KGV:
-9.9095
EPS:
-2.21
Netto-Cashflow:
$-106.82M
1W Leistung:
-1.75%
1M Leistung:
+7.09%
6M Leistung:
-23.43%
1J Leistung:
-42.97%
1-Tages-Spanne:
$21.71
$22.97
1-Wochen-Bereich:
$21.20
$23.07
52-Wochen-Spanne:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
21.90 | 1.44B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Best data tools to analyze Vera Therapeutics Inc. stockTreasury Yields & Community Verified Trade Alerts - Newser
Vera Therapeutics Inc. stock trendline breakdownBear Alert & AI Powered Buy/Sell Recommendations - Newser
Has Vera Therapeutics Inc. formed a bullish divergenceWeekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Momentum divergence signals in Vera Therapeutics Inc. chartTrade Signal Summary & Low Risk Entry Point Guides - Newser
Can trapped investors hope for a rebound in Vera Therapeutics Inc.Quarterly Portfolio Report & Reliable Breakout Forecasts - Newser
Signal strength of Vera Therapeutics Inc. stock in tech scanners2025 Top Decliners & Daily Profit Focused Screening - Newser
Volume spikes in Vera Therapeutics Inc. stock – what they mean2025 Market Trends & Detailed Earnings Play Strategies - Newser
Will Vera Therapeutics Inc. rebound enough to break evenQuarterly Trade Report & Precise Trade Entry Recommendations - Newser
Top chart patterns to watch in Vera Therapeutics Inc.Exit Point & AI Enhanced Trading Alerts - Newser
Price momentum metrics for Vera Therapeutics Inc. explainedMarket Growth Summary & Capital Protection Trading Alerts - Newser
Comparing Vera Therapeutics Inc. in custom built stock radarsMarket Performance Summary & Accurate Trade Setup Notifications - Newser
Can Vera Therapeutics Inc. continue delivering strong returnsGap Down & Real-Time Buy Zone Alerts - khodrobank.com
How to recover losses in Vera Therapeutics Inc. stockCEO Change & Smart Allocation Stock Reports - Newser
Why Vera Therapeutics Inc. is moving todayEarnings Trend Report & Advanced Swing Trade Entry Alerts - Newser
Is Vera Therapeutics Inc. forming a bottoming baseMarket Performance Recap & Real-Time Sentiment Analysis - Newser
Visual trend scoring systems applied to Vera Therapeutics Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Reversal indicators forming on Vera Therapeutics Inc. stockMarket Movers & Consistent Growth Equity Picks - Newser
Using AI based signals to follow Vera Therapeutics IncJuly 2025 Trade Ideas & Fast Gaining Stock Reports - Newser
Custom watchlist performance reports with Vera Therapeutics Inc.Weekly Gains Summary & High Conviction Trade Alerts - Newser
Does Vera Therapeutics Inc. have high return on assetsExit Point & Reliable Volume Spike Alerts - khodrobank.com
What high frequency data says about Vera Therapeutics Inc.July 2025 Momentum & Community Consensus Picks - Newser
Using AI based signals to follow Vera Therapeutics Inc.Quarterly Trade Report & High Conviction Investment Ideas - Newser
What institutional flow reveals about Vera Therapeutics Inc.July 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Published on: 2025-08-31 18:03:15 - Newser
Institutional scanner results for Vera Therapeutics Inc.July 2025 Snapshot & Stock Portfolio Risk Control - Newser
Visual trend scoring systems applied to Vera Therapeutics IncJuly 2025 Action & Verified Swing Trading Watchlist - Newser
Tools to assess Vera Therapeutics Inc.’s risk profileSwing Trade & Safe Investment Capital Preservation Plans - Newser
Vera Therapeutics Inc. stock prediction for this weekJuly 2025 Decliners & Target Return Focused Picks - Newser
What data driven models say about Vera Therapeutics Inc.’s futureTrade Analysis Summary & Verified Entry Point Detection - Newser
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vera Therapeutics Inc-Aktie (VERA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
| Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):